Related Experiment Video
Updated: Jun 21, 2025
05:53
Use of In vivo Imaging to Monitor the Progression of Experimental Mouse Cytomegalovirus Infection in Neonates
Published on: July 6, 2013
15.0K
Congenital CMV in the Neonate: A Primer.
Tiffany Bender1, Jamuna Buchanan1, Pradeeksha Mukuntharaj2
1University of South Dakota Sanford School of Medicine, Sioux Falls, South Dakota.
Summary
Congenital Cytomegalovirus (CMV) infection affects 0.64% of neonates, causing significant disabilities. This primer aids providers in diagnosing and treating this common perinatal viral infection.
Area of Science:
- Virology
- Neonatology
- Maternal-Fetal Medicine
Background:
- Cytomegalovirus (CMV) is a prevalent congenital virus, part of the TORCH complex.
- It is the leading cause of congenital infection in neonates, with a 0.64% prevalence.
- CMV is a primary cause of non-genetic hearing loss and neurodevelopmental disabilities in newborns.
Purpose of the Study:
- To provide a comprehensive overview of congenital Cytomegalovirus infection.
- To guide healthcare providers in the presentation, diagnosis, and treatment of congenital CMV.
- To support clinicians managing pregnant women, neonates, and pediatric patients affected by CMV.
Main Methods:
- This primer synthesizes current knowledge on congenital CMV.
- It reviews diagnostic approaches and therapeutic strategies.
- Information is presented for perinatal, neonatal, and pediatric healthcare providers.
Main Results:
- Congenital CMV remains a significant public health concern despite diagnostic advancements.
- Early diagnosis and intervention are crucial for mitigating long-term infant outcomes.
- Effective management strategies can improve the prognosis for affected neonates.
Conclusions:
- Congenital Cytomegalovirus infection requires prompt recognition and management.
- Understanding presentation, diagnosis, and treatment is essential for optimizing infant care.
- This primer serves as a vital resource for healthcare professionals addressing congenital CMV.
